Petros Pharmaceuticals, Inc. - Common Stock (PTPI)
0.2797
-0.0053 (-1.86%)
Petros Pharmaceuticals Inc is a company focused on developing and commercializing innovative pharmaceutical solutions primarily aimed at addressing the needs of men’s health, particularly in the areas of erectile dysfunction and related health issues
The company is dedicated to improving the quality of life for men through its product offerings, which include prescription medications designed to enhance sexual performance and overall well-being. By leveraging scientific research and a commitment to patient care, Petros Pharmaceuticals seeks to provide effective treatment options that empower men to take control of their health and relationships.
Frequently Asked Questions
Is Petros Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Petros Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Petros Pharmaceuticals, Inc. - Common Stock trade on?
Petros Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Petros Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Petros Pharmaceuticals, Inc. - Common Stock is PTPI on the Nasdaq Stock Market
What is the current price of Petros Pharmaceuticals, Inc. - Common Stock?
The current price of Petros Pharmaceuticals, Inc. - Common Stock is 0.2797
When was Petros Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Petros Pharmaceuticals, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025